Press release
Comprehensive 2025 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview: Trends, Forecasts, and Growth Drivers
Single Nucleotide Polymorphism (SNP) Genotyping
What Is the Expected CAGR for the Single Nucleotide Polymorphism (SNP) Genotyping Market Through 2025?
In recent years, the market size for single nucleotide polymorphism (SNP) genotyping has seen a massive expansion. The sector is predicted to scale up from $10.3 billion in 2024 to $12.37 billion in 2025 with a compound annual growth rate (CAGR) of 20.1%. The remarkable growth in the historical period is predominantly due to the surge in genomics research, escalation in genetic disorders, advent in personalized medicine, growth of the pharmaceutical industry, and the intensified need for molecular diagnostics.
What's the Projected Size of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market by 2029?
In the coming years, the single nucleotide polymorphism (SNP) genotyping market is projected to experience swift expansion, reaching $24.95 billion by 2029 with a compound annual growth rate (CAGR) of 19.2%. This growth during the prediction period can be attributed to its growing use in disease research, a surge in the need for precision medicine, the expansion of biobanking efforts, an increase in genetic testing, and its rising use in crop enhancement in agriculture. The forecast period will see key trends such as increased use of next-generation sequencing (NGS), a growing demand for SNP genotyping in pharmacogenomics, the rise of direct-to-consumer genetic testing, a focus on automation, and high-throughput genotyping platforms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report
Top Growth Drivers in the Single Nucleotide Polymorphism (SNP) Genotyping Industry: What's Accelerating the Market?
The surge in chronic conditions is predicted to fuel the expansion of the single nucleotide polymorphism (SNP) genotyping market. Chronic conditions, defined as ailments that persist over a year or longer, require ongoing medical attention and may limit daily activities. As the prevalence of chronic diseases rises, SNP genotyping becomes crucial in uncovering genetic predispositions and advancing customized medical treatments. For example, data from the Australian Institute of Health and Welfare, a governmental agency based in Australia, showed that the mortality rate tied to chronic conditions jumped from 459 deaths per 100,000 people in 2021 to 490 deaths per 100,000 people in 2022. As such, the escalating burden of chronic conditions underscores the growth potential of the SNP genotyping systems market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12569&type=smp
What Trends Will Shape the Single Nucleotide Polymorphism (SNP) Genotyping Market Through 2029 and Beyond?
The adoption of advanced technology is a rising trend observed in the single nucleotide polymorphism (SNP) genotyping market. Major market players are using innovative technologies to maintain their prominence in the market. For example, Neogen Corporation, an American firm specializing in food safety solutions for various industries, and Gencove, another US-Based firm known for sequencing solutions, jointly introduced InfiniSEEK in May 2022. This tool, the first of its kind, offers complete genome and genotyping capabilities for cattle breeders. The rigorous validation of InfiniSEEK confirms that its low-pass genome-wide sequencing is above 99% in harmony with deep whole-genome sequencing, offering superior clinical-grade accuracy in specific areas of interest.
What Are the Main Segments in the Single Nucleotide Polymorphism (SNP) Genotyping Market?
The single nucleotide polymorphism (SNP) genotyping market covered in this report is segmented -
1) By Product: Consumables, Instruments, Services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
Subsegments:
1) By Consumables: Reagents And Kits, DNA Probes, Microarrays
2) By Instruments: SNP Genotyping Platforms, Sequencers, PCR Machines
3) By Services: SNP Genotyping Services, Data Analysis Services, Consultation Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12569&type=smp
Which Top Companies are Driving Growth in the Single Nucleotide Polymorphism (SNP) Genotyping Market?
Major companies operating in the single nucleotide polymorphism (SNP) genotyping market include Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.
Which Regions Will Dominate the Single Nucleotide Polymorphism (SNP) Genotyping Market Through 2029?
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12569
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive 2025 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview: Trends, Forecasts, and Growth Drivers here
News-ID: 4100431 • Views: …
More Releases from The Business Research Company
Viral Diagnostic Test Kits Market Insights Highlight Segment Expansion And Marke …
The viral diagnostic test kits market is gaining significant traction as the world focuses more on pandemic preparedness and rapid disease detection. Innovations in testing technology and a rising need for decentralized healthcare solutions are driving this sector forward. Let's explore the market size, key players, emerging trends, and segment details shaping the future of viral diagnostic testing.
Projected Market Growth for Viral Diagnostic Test Kits
The viral diagnostic test…
Vertebroplasty Needles Market Report Evaluates Growth Drivers, Challenges And Ma …
The vertebroplasty needles market is set for remarkable growth as demand for spine-related procedures rises globally. With advancements in surgical techniques and a growing elderly population, this sector is poised to expand significantly in the coming years. Let's explore the expected market size, key drivers, leading players, and segmentation details that define this evolving landscape.
Projected Market Size Growth for Vertebroplasty Needles by 2030
The vertebroplasty needles market is anticipated…
Ventricular Assist Device Market Report Provides Insights Into Market Evolution …
The ventricular assist device market is gaining significant traction as advancements in cardiovascular technology continue to evolve. Driven by demographic changes and innovations in device design, this sector is set to experience substantial growth and transformation over the coming years. Let's explore the current market size, key players, emerging trends, and detailed segment analysis that define this dynamic industry.
Projected Market Size and Growth of the Ventricular Assist Device Market …
Vein Illumination Devices Market Research Explores Growth Within A $1.05 Billion …
The vein illumination devices market is poised for remarkable expansion as advancements in medical imaging technology continue to enhance patient care. With a growing focus on non-invasive procedures and improved accuracy in intravenous access, this sector is attracting significant attention from healthcare providers and technology developers alike. Below, we explore the market's valuation, key players, segmentation, and the main drivers behind its growth.
Projected Market Value and Growth of the Vein…
More Releases for SNP
The Rising Role Of SNP Genotyping In Chronic Disease Management: Strategic Insig …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Single Nucleotide Polymorphism (SNP) Genotyping Market Size By 2025?
The market dealing with single nucleotide polymorphism (snp) genotyping has experienced substantial expansion recently; projections indicate a rise from a valuation of $10.3 billion in 2024 to $12.34 billion in 2025, reflecting a robust compound annual…
SNP Genotyping Market to Reach USD 39.2 Bn by 2034
Introduction
Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation, occurring once in every 300 nucleotides on average. SNP genotyping has become a cornerstone of genomics, enabling researchers and clinicians to identify genetic predispositions, understand disease mechanisms, develop targeted therapies, and improve crop and livestock breeding.
The integration of high-throughput technologies, falling sequencing costs, and rising demand for personalized medicine are fueling market growth. By 2024, the SNP genotyping…
Booming SNP Genotyping Market: Rapid Growth, Major Players, and Emerging Trends
"The global single nucleotide polymorphism genotyping market showcases a robust growth rate powered by advancements and increasing demand in the field.
What Is The Projected Market Size Of The Global Single Nucleotide Polymorphism (SNP) Genotyping Market And Its Growth Rate?
The SNP genotyping market size has experienced rapid growth in recent years and is projected to continue this trend. Differences in data are as follows:
• Growth from $10.3 billion in 2024 to…
SNP genotyping Market 2023 Driving Factors Forecast Research 2029
SNP genotyping market is anticipated to grow at a significant CAGR of 20.5% during the forecast period. The market is mainly driven by increasing R&D projects in genotyping domain, and rising funding in the biotechnology industry. The biopharmaceutical companies are investing heavily in the R&D projects, attributed to advances and discoveries. From genomics to personalized medicines, all the recent advancement has created significant scope in developing unique treatment options for…
SNP genotyping Market Outlook 2029: Presents Market Insights & Depth Analysis
The global SNP Genotyping market is anticipated to grow at a CAGR of 20.5% during the forecast period (2023-2030). Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising…
Explore Single Nucleotide Polymorphism (SNP) Genotyping Market Demand 2020 - 202 …
According to a new report published by Allied Market Research, titled, "World Single Nucleotide Polymorphism (SNP) Genotyping Market - Opportunities and Forecasts, 2019-2026"
The global market size of Single Nucleotide Polymorphism (SNP) Genotyping is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan
Key…
